Aging disrupts the coordination between mRNA and protein expression in mouse and human midbrain

Silas A Buck,Samuel J Mabry,Jill R Glausier,Tabitha Banks-Tibbs,Caroline Ward,Jenesis Gayden Kozel,Chen Fu,Kenneth N Fish,David A Lewis,Ryan W Logan,Zachary Freyberg

DOI: https://doi.org/10.1101/2024.06.01.596950

2024-06-01

Abstract:Age-related dopamine (DA) neuron loss is a primary feature of Parkinsons disease. However, it remains unclear whether similar biological processes occur during healthy aging, albeit to a lesser degree. We therefore determined whether midbrain DA neurons degenerate during aging in mice and humans. In mice, we identified no changes in midbrain neuron numbers throughout aging. Despite this, we found age-related decreases in midbrain mRNA expression of tyrosine hydroxylase ( ), the rate limiting enzyme of DA synthesis. Among midbrain glutamatergic cells, we similarly identified age-related declines in vesicular glutamate transporter 2 ( ) mRNA expression. In co-transmitting neurons, and transcripts decreased with aging. Importantly, striatal Th and Vglut2 protein expression remained unchanged. In translating our findings to humans, we found no midbrain neurodegeneration during aging and identified age-related decreases in and mRNA expression similar to mouse. Unlike mice, we discovered diminished density of striatal TH+ dopaminergic terminals in aged human subjects. However, TH and VGLUT2 protein expression were unchanged in the remaining striatal boutons. Finally, in contrast to and mRNA, expression of most ribosomal genes in neurons was either maintained or even upregulated during aging. This suggests a homeostatic mechanism where age-related declines in transcriptional efficiency are overcome by ongoing ribosomal translation. Overall, we demonstrate species-conserved transcriptional effects of aging in midbrain dopaminergic and glutamatergic neurons that are not accompanied by marked cell death or lower striatal protein expression. This opens the door to novel therapeutic approaches to maintain neurotransmission and bolster neuronal resilience.

Neuroscience

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the transcriptomic changes of midbrain dopamine (DA) neurons during the aging process and their coordinated relationship with protein expression, especially whether this coordination is disrupted during healthy aging. Specifically, the research focuses on the following aspects:

1. **The influence of age on midbrain dopamine neurons**: By analyzing the tyrosine hydroxylase (TH) mRNA expression in the midbrains of young, middle - aged and old mice and humans, the researchers explored whether aging leads to changes in the number of midbrain dopamine neurons and a decrease in TH mRNA expression.

2. **Coordination between mRNA and protein expression**: The researchers further explored whether the decrease in TH mRNA expression during the aging process is accompanied by a decline in TH protein expression, and whether this change is conserved across species between mice and humans.

3. **Changes in glutamatergic neurons**: In addition to dopaminergic neurons, the study also focused on the age - related changes in the vesicular glutamate transporter 2 (VGLUT2) mRNA expression in midbrain glutamatergic neurons, and whether these changes affect the VGLUT2 protein expression.

4. **Expression of ribosomal genes**: The researchers also analyzed the expression changes of ribosomal genes during the aging process to explore whether there is a mechanism to maintain protein synthesis, thereby compensating for the decline in transcriptional efficiency.

Through these studies, the paper aims to reveal the molecular changes in midbrain dopaminergic and glutamatergic neurons during the aging process, and the impact of these changes on neural function, providing a theoretical basis for further developing strategies to delay or reverse neurodegenerative diseases.